Literature DB >> 688786

Left ventricular function in chronic obstructive pulmonary disease.

R G Kachel.   

Abstract

The presence or absence of left ventricular dysfunction in chronic obstructive pulmonary disease has been debated for decades. I have reviewed the following evidence pertaining to this topic: (1) left ventricular pathologic abnormalities; (2) the methods used to determine left ventricular performance; (3) specific abnormalities of left ventricular function as revealed by systolic time intervals, left ventricular end-diastolic pressure, ejection fraction, isovolumic indices, and left ventricular function curves; and (4) pertinent experimental data. The bulk of the evidence indicates that the clinical symtoms of left-sided failure are unreliable in those with obstructive disease of the airways and that the great majority of patients have normal left ventricular function, once other causes are excluded. A small group of patients have some abnormalities in left ventricular performance, but these have not been clinically significant. The ultimate importance of such abnormalities awaits future investigation.

Entities:  

Mesh:

Year:  1978        PMID: 688786     DOI: 10.1378/chest.74.3.286

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

2.  Haemodynamic effects of terbutaline in chronic obstructive airways disease.

Authors:  G J Teule; P A Majid
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

3.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Martin R Prince; Eric A Hoffman; David A Bluemke; Chia-Ying Liu; Dan Rabinowitz; Katja Hueper; Megha A Parikh; Antoinette S Gomes; Erin D Michos; João A C Lima; R Graham Barr
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.